- Home
- Publications
- Publication Search
- Publication Details
Title
Natural killer cell immune escape in acute myeloid leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume 26, Issue 9, Pages 2019-2026
Publisher
Springer Nature
Online
2012-03-26
DOI
10.1038/leu.2012.87
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?
- (2011) C. Ustun et al. BLOOD
- Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia
- (2011) Evelien L. J. Smits et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands
- (2011) Beatriz Sanchez-Correa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Role of Natural Killer Cells in Hematopoietic Stem Cell Transplantation: Myth or Reality?
- (2011) Stéphanie Nguyen et al. Journal of Innate Immunity
- Interferon-α in acute myeloid leukemia: an old drug revisited
- (2011) S Anguille et al. LEUKEMIA
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia
- (2011) S J Coles et al. LEUKEMIA
- High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2
- (2011) M.E.D. Chamuleau et al. LEUKEMIA RESEARCH
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Pre-eminence and persistence of immature natural killer cells in acute myeloid leukemia patients in first complete remission
- (2010) Nicolas Dauguet et al. AMERICAN JOURNAL OF HEMATOLOGY
- Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction
- (2010) G. Konjević et al. BIOMEDICINE & PHARMACOTHERAPY
- Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy
- (2010) Marco Ragusa et al. BMC CANCER
- Loss of natural killer activity as an indicator of relapse in acute leukaemia
- (2010) J. A. TRATKIEWICZ et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children
- (2010) M. M. Pfeiffer et al. HAEMATOLOGICA
- Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia
- (2010) Zhang Shenghui et al. INTERNATIONAL JOURNAL OF CANCER
- Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
- (2009) F. Romagne et al. BLOOD
- CD137 ligand mediates opposite effects in human and mouse NK cells and impairs NK-cell reactivity against human acute myeloid leukemia cells
- (2009) T. Baessler et al. BLOOD
- NK cell-mediated killing of target cells triggers robust antigen-specific T cell-mediated and humoral responses
- (2009) P. Krebs et al. BLOOD
- Early evaluation of natural killer activity in post-transplant acute myeloid leukemia patients
- (2009) G Pittari et al. BONE MARROW TRANSPLANTATION
- Induction of complete remission of acute myeloid leukaemia by pegylated interferon-α-2a in a patient with transformed primary myelofibrosis
- (2009) Zwi N. Berneman et al. BRITISH JOURNAL OF HAEMATOLOGY
- Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors
- (2009) Miroslaw J. Szczepanski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Protein Ligand Subverts Immunosurveillance of Acute Myeloid Leukemia in Humans
- (2009) T. Baessler et al. CANCER RESEARCH
- Natural Killer Cell IFN- Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor-Bearing Patients
- (2009) C. Menard et al. CANCER RESEARCH
- Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia
- (2009) C. Wu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
- (2009) M. J. Szczepanski et al. CLINICAL CANCER RESEARCH
- Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia
- (2009) Andrea Velardi et al. CURRENT OPINION IN IMMUNOLOGY
- Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells
- (2009) U. Langenkamp et al. HAEMATOLOGICA
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- Immunotherapy of Acute Myeloid Leukemia: Current Approaches
- (2009) E. L.J.M. Smits et al. ONCOLOGIST
- Combination Therapy Using IL-2 and Anti-CD25 Results in Augmented Natural Killer Cell–Mediated Antitumor Responses
- (2008) William H.D. Hallett et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
- (2008) S Nguyen et al. BONE MARROW TRANSPLANTATION
- NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
- (2008) Karl-Johan Malmberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Deregulation of the Mitochondrial Apoptotic Machinery and Development of Molecular Targeted Drugs in Acute Myeloid Leukemia
- (2008) G. Poeta et al. CURRENT CANCER DRUG TARGETS
- CD56brightnatural killer (NK) cells: an important NK cell subset
- (2008) Aurélie Poli et al. IMMUNOLOGY
- Immunotherapy for myeloid leukemias: current status and future directions
- (2008) K el-Shami et al. LEUKEMIA
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
- NKG2D ligands in tumor immunity
- (2008) N Nausch et al. ONCOGENE
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
- Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back
- (2007) Jacques Zimmer et al. LEUKEMIA RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started